상단으로
Choose your country
This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in each country.
Seegene Announces Licensing Agreement with Randox
Mar 31, 2009
Seegene, Inc. and Randox Laboratories today announced that they have entered into an agreement in which Randox will obtain a non-exclusive license to Seegene's Dual Priming Oligo (DPO™) technology to develop high-throughput diagnostic screening panels capable of simultaneously detecting a wide variety of infectious pathogens that cause either respiratory or sexually transmitted diseases.
See press releases about this article: click here